Adding clopidogrel to aspirin therapy reduces risk of second stroke

February 11, 2013, American Heart Association
Aspirin Bottle and pills 325 mg Dose. Credit: American Heart Association

Adding a second drug to aspirin therapy reduced the risk of a second stroke in the weeks after Chinese patients had a minor ischemic (due to a clot) stroke or a transient ischemic attack (TIA), according to research presented at the American Stroke Association's International Stroke Conference 2013.

A minor ischemic stroke is caused by a clot that blocks blood supply to the brain, but its effects are minimal. A TIA, sometimes known as a "mini stroke," occurs when a blood clot temporarily clogs an artery and blocks blood flow to the brain. TIAs and minor strokes don't typically cause permanent harm, but early treatment is critical to prevent the possibility of a major stroke with permanent neurological deficits.

"TIAs and minor strokes are emergencies," said S. Claiborne Johnston, M.D., Ph.D., senior author of the study and professor of neurology and director of the Stroke Service at the University of California, San Francisco. "If we start dual treatment early, it looks like we can reduce the risk of another stroke by more than 30 percent."

In comparison, alone cuts by about 20 percent, he said.

If you've had one or more TIAs, you're almost 10 times more likely to have a stroke than someone of the same age and sex who hasn't, according to the American Stroke Association.

The Clopidogrel in High-risk patients with Acute Non-disabling Cerebrovascular Events (CHANCE) study included 5,174 patients (median age 62, 34 percent women) with minor, clot-caused strokes or TIAs from 114 centers in China.

Within 24 hours, treatment was started with either low-dose aspirin (75-300 mg on the first day followed by 75 mg/day) plus a placebo or the same aspirin regimen plus clopidogrel (an initial 300 mg load followed by 75 mg/day for the first 21 days).

During the 90 days after treatment began, 8.2 percent of patients in the dual therapy group and 11.7 percent in the aspirin-only group experienced another stroke, a significant reduction with dual therapy.

Both aspirin and clopidogrel (Plavix) prevent small particles in the blood from sticking together and forming clots, so the investigators tracked bleeding incidents to see if dual therapy was safe. During the follow-up, seven (0.3 percent) in the dual therapy group and eight (0.3 percent) in the aspirin only group had a moderate or severe hemorrhage. Rates of bleeding strokes were also the same (0.3 percent).

The large trial is the first to demonstrate that combining clopidogrel with aspirin is safe and better protects against subsequent stroke. However, researchers aren't certain that the study's results apply to other populations.

"In China, stroke and patients are 6-8 years younger on average than Americans, and there are different genetic variations that have an impact on the metabolism of clopidogrel," said Yongjun Wang, M.D., study principal investigator, professor of neurology and vice-president of Beijing TianTan Hospital, Capital Medical University in Beijing, China.

In the United States, the ongoing Platelet-Oriented Inhibition in New TIA and Minor (POINT) trial led by Johnston is also testing dual therapy, with a higher loading dose of clopidogrel and treatment initiated within 12 hours of symptom onset. Results are due in 2016.

"In China, the combination therapy should now be used routinely and systems developed so that TIA and minor are not neglected and treatment is not delayed," Johnston said. "I suspect the study applies to U.S. patients and settings, but we really need to be sure with the POINT trial."

Explore further: Clopidogrel with aspirin doesn't prevent more small strokes, may increase risk of bleeding, death

Related Stories

Clopidogrel with aspirin doesn't prevent more small strokes, may increase risk of bleeding, death

February 3, 2012
The anti-blood clot regimen that adds the drug clopidogrel (Plavix) to aspirin treatment is unlikely to prevent recurrent strokes and may increase the risk of bleeding and death in patients with subcortical stroke according ...

Aspirin-clopidogrel no better than aspirin alone for patients with lacunar stroke

August 29, 2012
Aspirin combined with the antiplatelet drug clopidogrel is no better than aspirin alone for stroke prevention in people with a history of lacunar strokes, and the combination carries a greater risk of gastrointestinal bleeding, ...

TARDIS trial seeks new dimension in stroke treatment

October 17, 2011
People who suffer from acute stroke or Transient Ischaemic Attack (TIA, a mini stroke) could get better treatment in the future thanks to the expansion of a large clinical trial of a new combination of drugs led by researchers ...

'Mini' stroke can cause major disability, may warrant clot-busters

September 13, 2012
A transient ischemic attack, TIA or a "mini stroke," can lead to serious disability, but is frequently deemed by doctors too mild to treat, according to a study in the American Heart Association journal Stroke.

Recommended for you

Surgery involving ultrasound energy found to treat high blood pressure

May 23, 2018
An operation that targets the nerves connected to the kidney has been found to significantly reduce blood pressure in patients with hypertension, according to the results of a clinical trial led in the UK by Queen Mary University ...

New guidelines mean 1 in 3 adults may need blood pressure meds

May 23, 2018
(HealthDay)—One out of every three U.S. adults has high blood pressure that should be treated with medication, under guidelines recently adopted by the two leading heart health associations.

To have or not to have... your left atrial appendage closed

May 22, 2018
Each year in the U.S., more than 300,000 people have heart surgery. To reduce risk of stroke for their patients, surgeons often will close the left atrial appendage, which is a small sac in the left side of the heart where ...

Natural antioxidant bilirubin may improve cardiovascular health

May 18, 2018
Bilirubin, a yellow-orange pigment, is formed after the breakdown of red blood cells and is eliminated by the liver. It's not only a sign of a bruise, it may provide cardiovascular benefits, according to a large-scale epidemiology ...

New algorithm more accurately predicts life expectancy after heart failure

May 17, 2018
A new algorithm developed by UCLA researchers more accurately predicts which people will survive heart failure, and for how long, whether or not they receive a heart transplant. The algorithm would allow doctors to make more ...

New genes found that determine how the heart responds to exercise

May 17, 2018
A new study by researchers at Queen Mary University of London and University College London (UCL) has discovered 30 new gene locations that determine how the heart responds to and recovers from exercise.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.